The civic record
Read. Follow. Verify.Governor Kim Reynolds signs Senate File 233 allowing eligible patients access to unapproved investigational…
Last action · May 19, 2025: Signed by Governor . S.J. 1051 .
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Eligible patients with terminal, life-threatening, or severely debilitating illnesses are allowed to access unapproved investigational drugs, biological products, devices, and individualized treatments starting July 1, 2025. The legislation shields physicians from disciplinary actions and license revocation for recommending these treatments, protects patient heirs from inheriting related treatment debts, and prohibits state officials from blocking patient access.
Terminally or severely ill Iowa residents gain legal access to physician-recommended investigational drugs and personalized treatments that have cleared Phase 1 clinical trials but lack final federal approval, while assuming financial responsibility and exempting family members from resulting medical debt.
- Right to try laws are state-level statutes designed to allow terminally ill patients access to investigational drugs and medical devices that have not yet received final approval from the U.S. Food and Drug Administration. context
- Senate File 233 was introduced during the 91st General Assembly of the Iowa General Assembly, building upon prior statutory provisions originally designated under Senate File 56. context
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Eligible patients
Patients with terminal or debilitating illnesses gain legal access to unapproved investigational treatments and personalized therapies with physician recommendation.
Treating physicians
Physicians are protected from state medical board and Medicare certification penalties when recommending investigational treatments to eligible patients.
Manufacturers and eligible facilities
Manufacturers and eligible facilities are permitted to provide investigational products to eligible patients for free or at cost, without facing private lawsuits if they act in good faith.
Patient heirs
Heirs are explicitly exempted from liability for outstanding treatment debts if a patient passes away while receiving an investigational product.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Who qualifies as an eligible patient under the updated Right to Try Act?
Are health insurance companies required to cover the cost of investigational treatments?
Are a patient's heirs responsible for medical debts if the patient dies during treatment?
Can a doctor be penalized by the state for recommending an investigational drug?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
40 actions- May 19, 2025SenateEnrolledSigned by Governor . S.J. 1051 .
- May 19, 2025SenateReported correctly enrolled, signed by President and Speaker, and sent to Governor. S.J. 1050 .
- Apr 22, 2025HouseMessage from Senate. H.J. 1015 .
- Apr 22, 2025SenateImmediate message. S.J. 852 .
- Apr 22, 2025SenateFloorPassed Senate , yeas 46, nays 0. S.J. 849 .
- Apr 22, 2025SenateFloorSenate concurred with S-3038 . S.J. 849 .
Show 34 earlier actions
- Mar 25, 2025HouseExplanations of votes. H.J. 812 .
- Mar 25, 2025HouseExplanation of vote. H.J. 811 .
- Mar 24, 2025HouseMessage from House, with amendment S-3038 . S.J. 605 .
- Mar 21, 2025HouseWithdrawn. H.J. 772 .
- Mar 20, 2025HouseWithdrawn. H.J. 767 .
- Mar 20, 2025HouseSF 233 substituted. H.J. 758 .
- Mar 20, 2025HouseFloorAmendment H-1131 adopted. H.J. 758 .
- Mar 20, 2025HouseImmediate message. H.J. 767 .
- Mar 20, 2025HouseFloorPassed House , yeas 89, nays 0. H.J. 759 .
- Mar 20, 2025HouseFloorAmendment H-1132 adopted. H.J. 758 .
- Mar 20, 2025HouseSubstituted for HF 802 . H.J. 758 .
- Mar 19, 2025HouseAmendment H-1131 filed. H.J. 752 .
- Mar 19, 2025HouseAmendment H-1132 filed. H.J. 752 .
- Mar 18, 2025HousePlaced on calendar under unfinished business. H.J. 682 .
- Mar 18, 2025HouseIntroducedRead first time, passed on file. H.J. 681 .
- Mar 18, 2025HouseMessage from Senate. H.J. 680 .
- Mar 18, 2025SenateImmediate message. S.J. 559 .
- Mar 18, 2025SenateFloorPassed Senate , yeas 48, nays 0. S.J. 559 .
- Mar 5, 2025HouseIntroducedIntroduced, placed on calendar. H.J. 521 .
- Mar 5, 2025Iowa LegislatureCommittee report approving bill, renumbered as HF 802 .
- Mar 3, 2025HouseCommittee vote: Yeas, 14. Nays, 6. Excused, 1. H.J. 504 .
- Mar 3, 2025HouseCommittee report, recommending amendment and passage. H.J. 3 .
- Feb 19, 2025Iowa LegislatureSubcommittee recommends passage.
- Feb 17, 2025Iowa LegislatureSubcommittee Meeting: 02/19/2025 12:30PM RM 19.
- Feb 17, 2025HouseSubcommittee: Barker, Baeth and Bradley. H.J. 340 .
- Feb 11, 2025HouseIntroducedIntroduced, referred to Health and Human Services. H.J. 284 .
- Feb 10, 2025SenateCommittee report approving bill, renumbered as SF 233 . S.J. 219 .
- Feb 10, 2025SenateCommittee report, approving bill. S.J. 219 .
- Feb 10, 2025SenateIntroducedIntroduced, placed on calendar. S.J. 214 .
- Jan 27, 2025Iowa LegislatureSubcommittee recommends passage.
- Jan 23, 2025SenateSubcommittee Meeting: 01/27/2025 1:30PM Senate Lounge.
- Jan 22, 2025SenateSubcommittee reassigned: Alons, Celsi, and Klimesh. S.J. 126 .
- Jan 21, 2025SenateSubcommittee: Rowley, Campbell, and Celsi. S.J. 114 .
- Jan 16, 2025SenateIntroducedIntroduced, referred to Health and Human Services. S.J. 104 .
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expansion of Right to Try to Individualized Treatments
The updated act specifically broadens statutory definitions to include customized genetic treatments like gene therapy and neoantigen vaccines alongside traditional investigational drugs.
Connected Entities
Sources
www.legis.iowa.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools
